Type of prior genotoxic insult determines the genomic characteristics of therapy-related myeloid neoplasms.
Type of prior genotoxic insult determines the genomic characteristics of therapy-related myeloid neoplasms. Am J Hematol. 2021 07 01; 96(7):E223-E225.